BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 18434154)

  • 21. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
    Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
    Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles.
    Kuwabara S; Nemoto Y; Misawa S; Takahashi H; Kawaguchi N; Hattori T
    Acta Neurol Scand; 2007 Feb; 115(2):126-8. PubMed ID: 17212617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prepubertal anti-Musk positive myasthenia gravis with long remission.
    Gungor-Tuncer O; Orhan EK; Yilmaz V; Parman Y; Oflazer P; Saruhan-Direskeneli G; Deymeer F
    Neuromuscul Disord; 2014 Jan; 24(1):36-9. PubMed ID: 24074501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
    Leite MI; Ströbel P; Jones M; Micklem K; Moritz R; Gold R; Niks EH; Berrih-Aknin S; Scaravilli F; Canelhas A; Marx A; Newsom-Davis J; Willcox N; Vincent A
    Ann Neurol; 2005 Mar; 57(3):444-8. PubMed ID: 15732104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Methods for diagnosing seronegative myasthenia gravis].
    Blanco-Hernández T; Navarré-Gimeno A; Brocalero-Camacho A; Cervelló-Donderis A; López-Trigo J; Ortiz-Sánchez P; Sancho-Rieger J
    Rev Neurol; 2008 Mar 16-31; 46(6):360-4. PubMed ID: 18368681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
    Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M
    Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.
    Oh SJ; Hatanaka Y; Hemmi S; Young AM; Scheufele ML; Nations SP; Lu L; Claussen GC; Wolfe GI
    Muscle Nerve; 2006 Apr; 33(4):500-4. PubMed ID: 16392120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.
    Poulas K; Koutsouraki E; Kordas G; Kokla A; Tzartos SJ
    J Neuroimmunol; 2012 Sep; 250(1-2):94-8. PubMed ID: 22683336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A transient neonatal myasthenic syndrome with anti-musk antibodies.
    Niks EH; Verrips A; Semmekrot BA; Prick MJ; Vincent A; van Tol MJ; Jol-van der Zijde CM; Verschuuren JJ
    Neurology; 2008 Apr; 70(14):1215-6. PubMed ID: 18378885
    [No Abstract]   [Full Text] [Related]  

  • 31. Transient neonatal myasthenia gravis due to a mother with ocular onset of anti-muscle specific kinase myasthenia gravis.
    Lee JY; Min JH; Han SH; Han J
    Neuromuscul Disord; 2017 Jul; 27(7):655-657. PubMed ID: 28495046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A pregnant patient with anti-MuSK antibody positive myasthenia gravis and her infant with transient neonatal myasthenia gravis].
    Kanzaki A; Motomura M
    Rinsho Shinkeigaku; 2011 Mar; 51(3):188-91. PubMed ID: 21485163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune myasthenia gravis in childhood.
    Andrews PI
    Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal myasthenia gravis in the infant of a myasthenic mother in remission.
    Elias SB; Butler I; Appel SH
    Ann Neurol; 1979 Jul; 6(1):72-5. PubMed ID: 574370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients.
    Illa I; Diaz-Manera J; Rojas-Garcia R; Pradas J; Rey A; Blesa R; Juarez C; Gallardo E
    J Neuroimmunol; 2008 Sep; 201-202():90-4. PubMed ID: 18653247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to therapy in myasthenia gravis with anti-MuSK antibodies.
    Evoli A; Bianchi MR; Riso R; Minicuci GM; Batocchi AP; Servidei S; Scuderi F; Bartoccioni E
    Ann N Y Acad Sci; 2008; 1132():76-83. PubMed ID: 18567856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired myasthenia gravis in childhood.
    Evoli A
    Curr Opin Neurol; 2010 Oct; 23(5):536-40. PubMed ID: 20581680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.
    Zhou L; McConville J; Chaudhry V; Adams RN; Skolasky RL; Vincent A; Drachman DB
    Muscle Nerve; 2004 Jul; 30(1):55-60. PubMed ID: 15221879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR; Flink R; Askmark H; Stålberg EV
    Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.